EC Number |
Inhibitors |
Structure |
---|
1.21.99.3 | (2E)-2-(3,4-dihydroxybenzylidene)-4,6-dihydroxy-1-benzofuran-3(2H)-one |
aurone derivative isolated from plant extract. Comparison with inhibition of 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | (2E)-2-(3,4-dihydroxybenzylidene)-6-hydroxy-1-benzofuran-3(2H)-one |
aurone derivative isolated from plant extract. Comparison with inhibition of 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | (2E)-4,6-dihydroxy-2-(4-hydroxy-3-iodobenzylidene)-1-benzofuran-3(2H)-one |
aurone derivative isolated from plant extract. Comparison with inhibition of 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | (2E)-4,6-dihydroxy-2-(4-hydroxybenzylidene)-1-benzofuran-3(2H)-one |
aurone derivative isolated from plant extract. Comparison with inhibition of 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | (4-[(E)-(4,6-dihydroxy-3-oxo-1-benzofuran-2(3H)-ylidene)methyl]phenoxy)acetic acid |
aurone derivative isolated from plant extract. Comparison with inhibition of 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | 2-(3,4-dihydroxybenzyl)-4,6-dihydroxy-1-benzofuran-3(2H)-one |
aurone derivative isolated from plant extract. Comparison with inhibition of 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | 3',4',4,6-tetrahydroxyaurone |
inhibition kinetics; very potent naturally occuring plant-derived inhibitor, conformation study |
|
1.21.99.3 | 3',5'-diiodothyronine |
comparison with 5'-deiodinase EC 1.97.1.10 |
|
1.21.99.3 | 3,3',5'-triiodo-L-thyronine |
substrate inhibition |
|
1.21.99.3 | 3,3',5'-triiodo-L-thyronine |
75% inhibition at 0.01 mM; substrate inhibition |
|